Status:
COMPLETED
Visual Acoustic Biofeedback for RSE Via Telepractice
Lead Sponsor:
Montclair State University
Collaborating Sponsors:
National Institute on Deafness and Other Communication Disorders (NIDCD)
New York University
Conditions:
Speech Sound Disorder
Eligibility:
All Genders
9-15 years
Phase:
PHASE2
Brief Summary
This research will meet a public health need by evaluating the efficacy of speech intervention supplemented with real-time visual-acoustic biofeedback when delivered using remote technologies.
Detailed Description
In a crossover design, participants will be randomly assigned to receive 10 weeks/20 sessions of visual-acoustic biofeedback treatment via telepractice followed by a 10-week period of no treatment, or...
Eligibility Criteria
Inclusion
- Must be between 9;0 and 15;11 years of age at the time of enrollment.
- Must speak English as the dominant language (i.e., must have begun learning English by age 2, per parent report).
- Must speak a rhotic dialect of English.
- Must pass a pure-tone hearing screening at 20dB hearing level.
- Must pass a brief examination of oral structure and function.
- Must exhibit less than 30% accuracy, based on consensus across 2 trained listeners, on a probe list eliciting rhotics in various phonetic contexts at the word level.
- Must exhibit no more than 3 sounds other than /r/ in error on the Goldman-Fristoe Test of Articulation-3 (GFTA-3).
Exclusion
- Must not receive a T score more than 1.3 SD below the mean on the Wechsler Abbreviated Scale of Intelligence-2 (WASI-2) Matrix Reasoning
- Must not receive a scaled score of 7 or higher on the Recalling Sentences and Formulated Sentences subtests of the Clinical Evaluation of Language Fundamentals-5 (CELF-5).
- Must not have an existing diagnosis of developmental disability or major neurobehavioral syndrome such as cerebral palsy, Down Syndrome, or Autism Spectrum Disorder
Key Trial Info
Start Date :
January 15 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 15 2024
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT04858022
Start Date
January 15 2022
End Date
April 15 2024
Last Update
July 29 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Montclair State University
Upper Montclair, New Jersey, United States, 07403